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Abstract
 Developed a multifunctionalized DDs that combines high
specificity towards cancer cells with endosomal escape
capabilities
 The polymeric engineering here developed enhances the
performance of DDS at low drug dose, holding great
potential for anticancer therapeutic applications.
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Introduction
Why Mesoporous Silica Nanoparticles?!!
(MSNP)
 Biocompatibility 
 High loading capacity  
 Chemical stability
 Straightforward synthesis/surface functionalization
Have not been translocated into the clinical stage yet!!
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To promote the specific internalization of nanoparticles to
certain cancer cells;
Employment of specific ligands, which can bind to receptors
overexpressed in tumor cells and trigger particle
internalization via endocytosis
Hyaluronic acid & Glycoprotein receptor overexpressed in 
many solid tumor cells 
(HA)              (CD44)
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 External materials taken up via endocytosis
 Normally sorted out in Endocytic vesicles (endosomes & 
lysosomes)
 Ejected to the extracellular matrix via Exocytosis
What is the problem ????
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Non-Coated MSNPs co-localize with the endo-
/lysosomes in the early stage of incubation, & are 
quickly exocytosed
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HA-coated MSNPs are internalized via CD44-mediated Endocytosis
& are subjected to same endocytic system, ending up in the acidic
cellular compartments within few hours of incubation, & being
ejected via exocytosis within 48 h
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Problems in DDs
 The Endo-/Exocytosis process
 The Low lysosomal pH (4.5–5.5 for normal cells and 3.5–5 for
cancer cells)
 The strong Enzymatic activity
 The Fast exocytosis of the Nanocarriers
 The DDS can be exocytosed to the extracellular matrix before 
releasing all its cargo
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So:
The employment of Cationic Polymers, in particular Polyethylenimine
(PEI), is a promising strategy, as it is non-immunogenic and easier to scale
up, compared to other agents, such as synthetic fusogenic peptides.
&
“Proton Sponge Effect” of PEI
12
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Assume
 the Endosomolytic activity of the PEI layer
 the addition of a PEI layer can slow down the Exocytosis rate of 
MSNPs
 A facile method to functionalize MSNPs with a polymeric 
bilayer, which simultaneously combines the active targeting 
action of HA & PEI-mediated endosomal escape
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Material 15
Methods: 
1- HAPEI-MSNps Preparation:
synthesis of MSNPs The loading of RhodB and FITC
MSNPs dispersed in phosphate buffer (pH 9) to increase the loading efficiency
the Dox soaking mixtures under magnetic stirring (500 rpm) overnight
MSNPs_RhodB/FITC/Dox
PEI in H2O at pH 7 and added to loaded-MSNPs in milli-Q water about 3 h under magnetic
stirring HA were dissolved in 10 mL of MES buffer stirring for 30 minutes for the
activation of the carboxylic groups carboxyl-activated HA added to 3 mL of PEI-MSNPs_X
HAPEI-MSNPs_X
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 Analyzed with UV-VIS spectrometer  in order to estimate 
the soaked cargo concentrations via absorbance
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Methods
HAPEI-MSNps - X characterization:
 transmission electron microscopy (TEM): for size, shape & porosity
 collecting wide-field images and the relative emission spectrum of
MSNPs_Dox/RhodB/ FITC: The loading
 inverted optical microscope (TiU, Nikon): measurements
 Nd:YAG laser : applied on RhodB samples
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Methods
Cellular uptake:  NIH3T3 and A549 cell lines 
All cells                                                                                in DMEM medium 
containing 10% FBS, 1% L-glutammax and 0.1% gentamicin
Then 
cultured in 35-mm glass bottom dishes for confocal imaging
 (NIH3T3 cell lines: Embryonic fibroblast cells)
 (A549 cell lines: Adenocarcinomic human alveolar basal epithelial cells)
at 37 °C, 5% CO2, 
in 25 cm2 cell culture flasks
the confluency reached 80%
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Methods
Cellular uptake:
For verifying the effect of different functionalization on the uptake;
RhodB-loaded particles (MSNPs_RhodB, PEI-MSNPs_RhodB &HAPEI-
MSNPs_RhodB)
I. incubated with NIH3T3 and A549 cells
II. plasma membrane was stained with DiO
III. visualized under a Confocal Fluorescence Microscope
IV. Fluorescence intensity analysis was performed by MATLAB software
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Methods
Intracellular trafficking: fluorescence microscopy
 FITC : In order to track the intracellular fate of the particles (MSNPs_FITC,
PEI-MSNPs_FITC, HAPEI-MSNPs_FITC) with A549 cells for 3 h.
 Washed with PBS three times : remove the residual extracellular particles
 Confocal fluorescence measurements after the washing (data of 3 h of incubation)
(other copies of the same samples in fresh medium and placed back in the incubator for measurements after 24 and 48 h)
 stained with Lysotracker Red: For the acidic compartment imaging, endo/ lysosomes
 Images were processed using FV10-ASW Viewer Software
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 Pearson correlation coefficient (PCC) analysis by using MATLAB 
software
PCC values indicate that:
Near 0 the fluorescence intensities of the two channels are 
uncorrelated
Close to 1 the two fluorescence intensities are perfectly linearly 
related
22
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Methods 
Drug release in vitro:
1) 3 different pH buffers: Acetate buffer (pH 4.5), MES buffer (pH 6) and PBS
(pH 7.4)
2) Add Dox-incorporated particles
3) Hyal-1 and Hyal-2 add to HAPEI-MSNPs_Dox in acetate and MES buffer for…
4) at different incubation time (0–72 h),
5) Estimate the concentration of the Dox released by collecting the absorbance at 490
nm.
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Methods 
Drug release in Cellulo.:
10 μL of HAPEI-MSNPs_Dox + 1 mL of medium containing A549 cells
 in the incubator for 3 h
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Methods
Anticancer efficiency:
Carry out viability tests;
I. Seed the cells with 1 mL of medium
II. aliquots of 2, 4, 6, 8 and 10 μL solutions containing HAPEI-MSNPs_Dox, free Dox & 
empty HAPEI-MSNPs (Dox= 80, 160, 240, 320 and 400 nM & particles= 20, 40, 60, 80, 100 μg/mL)
III. Incubated overnight, wash & …
IV. The viability was estimated: after the treatment (HAPEI-MSNPs_Dox, free Dox and empty particles) 
with a control dish 
V. KOVA system protocol
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Results & Discussion
Preparation and characterization of multifunctional MSNPs.:
 Synthetize MSNPs using the biphase stratification method that particles 
with a pore size of ~2.8 nm
 Properties: size (120nm) & shape homogeneity, 
No aggregates & uniform mesoporous frame 
TEM  images of uncoated MSNPs
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Cargo loading into MSNPs: wide-field fluorescence images (a-c) and relative emission spectra (insets) of
MSNPs loaded with RhodB (a), FITC (b) and Dox (c). Emission spectra were collected by focusing the laser
on one bright spot.
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 MSNPs were coated with PEI for providing the DDS with endosomal
escape capability
 ionization percentage enables the formation of a PEI shell on the MSNP
surface via electrostatic interaction. The presence of the PEI layer on
MSNPs was demonstrated by the drastic change in the zeta potential of the
particles after the coating
Results & Discussion 29
after conjugation with HA, the edge contrast increases, The halo displayed in Fig. e,f was
never observed for bare MSNPs (FE-SEM images)
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Results & Discussion
Cellular uptake: HA-mediated active targeting;
 Different particles into two mammalian cell lines for targeting efficiency & the cell 
specificity of the external functionalization with HA
 RhodB-loaded MSNPs with different coatings + A549 cells (CD44-overexpressing cells)
&  NIH3T3 (CD44-inactive cells)
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Influence of surface modification on the cellular uptake of MSNPs.
(Fluorescence images )
Results & Discussion

Intracellular trafficking: PEI-induced endosomal rupture
Results & Discussion
 coating of nanoparticles with specific polymers the rupture of the endo-/lysosomes
and further escape to the cytosol
 Both fluorescence and electron microscopy images demonstrate an of the
endosomal escape efficiency with HA-PEI coating compared to using PEI alone
 At low pH, the inclusion of an extra polymeric layer can, both the buffering
capacity and the polymeric swelling, contributing to the destabilization of the endo-
/lysosomal membrane.
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Results & Discussion
Drug release in vitro:
 Doxorubicin for therapeutic effectiveness & fluorescent properties
 DDSs should combined with a controlled release at the specific target.
 bare MSNPs, the environmental pH plays a crucial role on the drug release
kinetics. the release rate of Dox in vitro is at acidic pH, although a relatively
smaller amount can be released at neutral pH as well.
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Results & Discussion
 the HA-PEI polymeric bilayer will function as a capping agent, preventing the
leakage of the drug before reaching the intracellular environment
 At neutral pH, according to the pKa values of PEI and silica hydroxyl groups, the
electrostatic interactions guarantee a stable attachment of the PEI shell to the
particles, the discharge of Dox in blood circulation
 At acidic pH, as the majority of the hydroxyl groups of the silica particles are
protonated, the electrostatic interactions are minimized, the capping effect of the
polymeric coating and the drug release in the cellular acidic compartments
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only enzyme-mediated degradation of the polymeric coating, which occurs exclusively in the
cellular environment, triggers drug release from the particles
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Drug release in Cellulo.:
Fluorescence images of Dox released from HAPEI-MSNPs_Dox inside A549 cells after 3, 24 and 48 h
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Results & Discussion
Anticancer Efficiency: cell viability 
tests:
In order to evaluate the efficiency
polymer-coated particles as anticancer
DDSs, cell viability 72 h after treatment
with free Dox, Dox-loaded HAPEI-
MSNPs & empty HAPEI-MSNPs, at
different concentration of drug/particles
 (high uptake, endosomal escape &
controlled drug released)
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Results & Discussion
 our DDS has great therapeutic potential, specifically towards CD44-overexpressing
cancer cells
 The high therapy efficiency achieved at low drug concentrations is strictly related
to:
• the fast internalization rate (HA coating targeting effect)
• to the improved endosomal release (with consequent retention of the particles in the cytoplasm ,HA-
PEI shell inducing endosomal rupture),
• control drug release overtime (enzymatic polymeric digestion)
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Results & Discussion
1) HA & PEI layers provide the DDs with active targeting & endosomal
escape capability, enhancing the therapeutic efficiency
2) Dox-loaded HAPEI-MSNPs exhibit great killing efficiency at low drug
concentrations, which was comparable with that of pure Dox, but with
specificity towards CD44-overexpressing cancer cells
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Great potential DDs for tumor therapy applications ;
 endosomal escape capacity
 controlled drug release
 Consequently
 high therapeutic effect
 targeting capability towards cancer cells
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Future Perspective
 The polymeric functionalization proposed can be applied to a wide
range of nanocarriers towards the increase of the therapeutic power
at low drug dose and the decrease of exocytosis rate, drastically
reducing the side effects of anti-cancer drugs.
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